SARS-CoV-2: pathogenesis, therapeutics, variants, and vaccines

Area of Science:

• Virology and Immunology
• Pathogenesis of Infectious Diseases

Background:

• Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, led to a global pandemic with severe economic and health impacts.
• SARS-CoV-2's unique structure and pathogenic mechanisms contribute to its virulence and the triggering of detrimental immune responses like cytokine storms.

Purpose of the Study:

• To characterize the structural features of SARS-CoV-2 and its variants.
• To elucidate the interaction between SARS-CoV-2 and the immune system, focusing on immune dysregulation and cytokine storm.
• To review potential therapeutic strategies for managing COVID-19, including addressing viral elimination and immune response control.

Main Methods:

• Literature review and analysis of existing research on SARS-CoV-2 structure, pathogenesis, and host immune responses.
• Characterization of viral variants and their genomic mutations affecting transmissibility and virulence.
• Exploration of current and potential therapeutic interventions.

Main Results:

• SARS-CoV-2's structure and mutations influence its binding affinity, immune escape, and virulence.
• Dysfunctional immune responses and cytokine storms are critical drivers of severe COVID-19.
• Understanding host-pathogen interactions aids in prevention, early detection, and vaccine development.

Conclusions:

• Effective COVID-19 management requires targeting both the virus and the aberrant immune responses.
• Further research into SARS-CoV-2 variants and immunopathology is crucial for developing improved treatments and mitigating public health crises.